2Papatheodoridis GV, Hadziyannis SJ. Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther, 2004,19: 25-37.
3Asahina Y, Izumi N, Uchihara M, et al. Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens. J Hepatol, 2003, 39: 421-427.
4Lin KW, Kirchner JT. Hepatitis B. Am Fam Physician, 2004, 69:75-82.
5Zhu H, Zhao H, Collins CD, et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.Hepatology, 2003, 37:1180-1188.
6Gordien E, Rosmorduc O, Peltekian C, et al. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol,2001, 75: 2684-2691.
7Torisu H, Kusuhara K, Kira R, et al. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis.Neurology, 2004, 62: 457-460.
8King JK, Yeh SH, Lin MW, et al. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study. Hepatology, 2002, 36: 1416-1424.
9Knapp S, Yee LJ, Frodsham AJ, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun, 2003, 4:411-419.
10Fernandez M, Quiroga JA, Carreno V. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol, 2003, 84(Pt 8):2073-2082.
同被引文献12
1Allison RD, Conry-Cantilena C, Koziol D, et al. A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors[J]. J Infect Dis, 2012, 206(5) : 654 -661.
2Bukh J. Animal models for the study of hepatitis C virus infection and related liver disease[ J]. Gastroenterology, 2012, 142 ( 6 ) : 1279 - 1287.
3Mekky RY, Hamdi N, El-Akel, et al. W Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients [ J ]. Transl Res, 2012, 159(3) : 190 -196.
4Ching JC, Chan KY, Lee EH, et al. Significance of the myxovirus resistance A(MxA) gene -123C > a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection[J]. J Infect Dis, 2010, 201 (12) : 1899 -1908.
5Cao B, Liu X, Hou F, et al. The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population [J]. Liver Int, 2009, 29(9) : 1383 -1388.
6Knapp S, Yec LJ, Frodsham AJ, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR[J]. Genes and Immunity, 2003, 4(6) : 411 -419.
7Colombatto P, Civitano L, Oliveri F, et al. Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase[J]. Antivir Ther, 2003, 8(6): 519-530.
8Dharel N, Kato N, Muroyama R, et al. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus [J]. Hepatology, 2008, 47(4) : 1136 -1149.
9De Lucas S, Bartolome J, Carreno V. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes [J]. J Infect Dis, 2005, 191(1): 93 -99.
